Back to search

Article

GLP-1 analogs restore inflammatory, mitochondrial and intercellular signaling networks in the <i> Snca <sup>G51D/G51D</sup> </i> knock-in mouse model of Parkinson’s disease

2026-05-19

Abstract excerpt

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a prolonged prodromal stage that culminates in motor deficits. Current PD therapies primarily alleviate symptoms, underscoring the need for disease-modifying strategies. Glucagon-like peptide-1 (GLP-1) analogs showed early promise as candidate disease modifiers, but recent clinical results have been inconsistent, and their mechanism of actio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3bc8df5c-0b5f-5355-bba2-dc1f5287a1e4
DOI
10.64898/2026.05.18.726024
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GLP-1 analogs restore inflammatory, mitochondrial and intercellular signaling networks in the <i> Snca <sup>G51D/G51D</sup> </i> knock-in mouse model of Parkinson’s diseaseDOI 10.64898/2026.05.18.726024
Select a neighboring publication to make it the new centre.